Spectrum of Presentations and Management Strategies in Renal Angiomyolipoma

J Kidney Cancer VHL. 2022 Jan 28;9(1):42-47. doi: 10.15586/jkcvhl.v9i1.221. eCollection 2022.

Abstract

Renal angiomyolipoma (rAML) occurs rarely sporadically but is commonly encountered in patients with tuberous sclerosis complex and lymphangioleiomyomatosis. rAML is a rare entity, not seen regularly in daily practice; however, is commonly encountered and diagnosed by clinicians who approach and treat kidney masses. Basic knowledge of this entity is necessary to recognize that despite being benign, these tumors can rarely cause deadly complications such as hemorrhage or severe renal dysfunction or may have malignant components associated with them.

Keywords: PEComa; angiomyolipoma; epithelioid renal angiomyolipoma; mTOR inhibitors.

Publication types

  • Editorial